Lupin secures tentative USFDA nod for multiple sclerosis drug Siponimod Ruchika Sharma5 Dec 2025 11:10 AM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...
Lupin enters into licensing agreement with Valorum for biosimilar Armlupeg in US Ruchika Sharma4 Dec 2025 2:14 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has entered into an Exclusive Licensing Agreement with Valorum Biologics, a ...
Lupin Eyes Rs 11,800 Crore Vitabiotics Buyout, Lalvani Family-Owned Brand in Focus Farhat Nasim3 Dec 2025 6:13 PM ISTMumbai: Indian pharma major Lupin, alongside private-equity firms TPG Capital and EQT Partners, is reportedly in early-stage discussions to acquire...
Lupin's Phase IV Report for Glycopyrronium, Vilanterol Inhalation Gets CDSCO Panel Nod Parthika Patel3 Dec 2025 5:02 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has accepted the Phase IV clinical trial...
Lupin secures USFDA nod for biosimilar Armlupeg Ruchika Sharma1 Dec 2025 10:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has approved Armlupeg...
Lupin Foundation bags CRISIL Highest VO 1A Rating Ruchika Sharma28 Nov 2025 12:30 PM ISTMumbai: Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of global pharma major Lupin Limited,...
Lupin gets seven USFDA observations for Goa facility Ruchika Sharma22 Nov 2025 11:43 AM ISTMumbai: Lupin has announced that the company has received seven observations from the U.S. Food and Drug Administration (USFDA) after an...
Lupin secures S&P Global ESG Score of 91 for 2025 Ruchika Sharma17 Nov 2025 12:34 PM ISTMumbai: Global pharma firm Lupin Limited has announced that it has achieved an S&P Global ESG Score of 91 for 2025, well above the...
Lupin Nagpur facility completes USFDA inspection Ruchika Sharma15 Nov 2025 5:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a product...
Lupin unveils Risperidone Long Acting Injectable in US Ruchika Sharma14 Nov 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Risperidone for extended-release injectable suspension, 25 mg per vial,...
Lupin gets EIR from USFDA for Aurangabad Facility Ruchika Sharma13 Nov 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...
Lupin Manufacturing Solutions unveils Oncology block at Vizag Ruchika Sharma12 Nov 2025 1:30 PM ISTMumbai: Lupin Manufacturing Solutions, a wholly owned subsidiary of global pharma major Lupin Limited, has announced the commissioning of its...
